About EBioMedicine
EBioMedicine Stay current with the latest in all disciplines of life and health sciences with the EBioMedicine app, all with just a tap. Now available for both android smartphones and tablets! • Stay ahead with alerts...
EBioMedicine
Stay current with the latest in all disciplines of life and health sciences with the EBioMedicine app, all with just a tap. Now available for both android smartphones and tablets!
• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope and the 3D Radiological Viewer
• Get access to the journal content on the app via your institution’s IP
• Enjoy Open Access and Open Archive Content without having to login
• Accessibility support to assist the visually impaired
• Interact with figures, tables, multimedia and supplementary content
• Take notes, highlight articles and share via email and social media
• Personalize your experience with My Reading List and save articles for offline reading
About EBioMedicine
The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
As the communities that border this interface are large and diverse, the scope of EBioMedicine will cover the entire breadth of translational and clinical research within all disciplines of life and health sciences, ranging from basic science to clinical and public/global health science. The journal will also place a high priority on rapid publication. The journal seeks to publish a broad range of research study types, from experimental findings, critical analyses, methodological & technical innovations, and hypotheses to observational epidemiological studies, clinical trials, meta-analyses, and study protocols. In addition, EBioMedicine will publish commentaries, reviews, and viewpoints that enhance the accessibility and applicability of basic research findings for health professionals, and promote a better understanding of clinical challenges for biomedical researchers.
In leveraging the editorial leadership from Cell and The Lancet together with the publishing expertise of Elsevier to create a unique forum for the reputable and speedy publication of research in life and health sciences, we are committed to facilitating and incentivizing a robust and successful pipeline for improved human health globally.
Our privacy policy is here: http://www.elsevier.com/EULA_non-Apple_apps
Previous Versions
Here you can find the changelog of EBioMedicine since it was posted on our website on 2016-12-24 17:50:17.
The latest version is 7.2.0 and it was updated on 2024-04-23 10:55:42. See below the changes in each version.
EBioMedicine version 7.2.0
Updated At: 2018-01-10
Changes: • Completely updated and refreshed User Interface
◦ Modernized with current design language
◦ Improved navigation— more logical and efficient
◦ Natural integration of past features
• Bug fixes and performance enhancements
EBioMedicine version
Updated At: 2016-10-03
Changes: • Content Innovation Enhancement,• Video/Audio streaming,• Added support for Android 6.0 runtime permissions,• Improved Downloads,• Fixes to known issues,• Institutional access extended for off-site access
Disclaimer
External Download
We do not host EBioMedicine on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Galad and passed their terms and conditions to be listed there. We recommend caution when installing it.
The APK Download link for EBioMedicine is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
